Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.69 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1144284 | 1.00 | HRH3 (0.69) | HRH3TERTPTPN1PPARGPPARD | |
| SCHEMBL1144283 | 1.00 | HRH3 (0.69) | HRH3TERTPTPN1PPARGPPARD | |
| SCHEMBL22891559 | 0.94 | HRH3 (0.61) | HRH3TERTPTPN1PPARGPPARD | |
| SCHEMBL9828332 | 0.91 | HRH3 (0.54) | HRH3PTPN1PPARGPPARDPPARA | |
| SCHEMBL9828329 | 0.91 | HRH3 (0.54) | HRH3PTPN1PPARGPPARDPPARA | |
| SCHEMBL9829055 | 0.85 | ALDH1A1 (0.47) | HRH3MAPTKMT2ANPSR1FAAH | |
| SCHEMBL9829061 | 0.85 | ALDH1A1 (0.47) | HRH3MAPTKMT2ANPSR1FAAH | |
| SCHEMBL16620112 | 0.84 | HRH3 (0.66) | HRH3TERTPTPN1PPARGPPARD | |
| SCHEMBL16620111 | 0.84 | HRH3 (0.66) | HRH3TERTPTPN1PPARGPPARD | |
| SCHEMBL7739091 | 0.82 | HRH3 (1.00) | HRH3TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220000814-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2022-01-06 | — | — | US | disclosed |
| US-20220000814-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2022-01-06 | — | — | US | disclosed |
| US-11058652-B2 | Methods for treatment of Prader-Willi syndrome | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| US-11058652-B2 | Methods for treatment of Prader-Willi syndrome | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| EP-3432874-B1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2021-01-13 | — | — | EP | disclosed |
| EP-3432874-B1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2021-01-13 | — | — | EP | disclosed |
| US-20190151264-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-05-23 | — | — | US | disclosed |
| US-20190151264-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-05-23 | — | — | US | disclosed |
| EP-3432874-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2019-01-30 | — | — | EP | disclosed |
| WO-2017179058-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2017-10-19 | — | — | WO | disclosed |
| WO-2017179058-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2017-10-19 | — | — | WO | disclosed |
| US-8198327-B2 | Fatty acid amides and uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-06-12 | — | — | US | disclosed |
| US-8198327-B2 | Fatty acid amides and uses thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2012-06-12 | — | — | US | disclosed |
| US-20110046222-A1 | FATTY ACID AMIDES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2011-02-24 | — | — | US | disclosed |
| US-20110046222-A1 | FATTY ACID AMIDES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2011-02-24 | — | — | US | disclosed |
| WO-2009125409-A2 | FATTY ACID AMIDES AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046222-A1 | FATTY ACID AMIDES AND USES THEREOF | FASN, FADS1, ELOVL5 | HRH3 601/4885TERT 4315/4885PTPN1 4384/4885 |
| US-20190151264-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | EBP, MECP2, PRKD3 | HRH3 2365/4885TERT 4258/4885PTPN1 3202/4885 |
| US-20220000814-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | MECP2, BHMT2, EBP | HRH3 2188/4885TERT 4323/4885PTPN1 2659/4885 |
| US-11058652-B2 | Methods for treatment of Prader-Willi syndrome | EBP, MECP2, PRKD3 | HRH3 2365/4885TERT 4258/4885PTPN1 3202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.